Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escalating Doses of CINRYZE in HAE
NCT00914966Phase 4Completed
- Sponsor
- Takeda
- Start
- Aug 2009
- Primary completion
- May 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of c1-esterase inhibitor in hereditary angioedema (HAE), sponsored by Takeda. Started Aug 2009; status: completed.
02
Drugs
c1-esterase inhibitor
03
Conditions
hereditary angioedema (HAE)
Beyond the preview
Go deeper on NCT00914966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00914966.